Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Jul 16;10(7):1136.
doi: 10.3390/vaccines10071136.

Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History

Affiliations
Case Reports

Two Pediatric Cases of Multisystem Inflammatory Syndrome with Overlapping Neurological Involvement Following SARS-CoV-2 Vaccination and Unknown SARS-CoV2 Infection: The Importance of Pre-Vaccination History

Veronica Santilli et al. Vaccines (Basel). .

Abstract

The SARS-CoV-2 vaccine roll-out has been successful around the world. However, there are increasing concerns about adverse events. We report two pediatric cases of Multisystem-Inflammatory-Syndrome (MIS-C) with neurological involvement that occurred after SARS-CoV-2 vaccination and unknown recent SARS-CoV-2 infection. Brain magnetic resonance revealed mild-encephalopathy with reversible-splenial-lesion in both cases and complete resolution within 4 weeks. In conclusion, this report aims to describe rare emerging clinical entities that can help pediatricians to make an early diagnosis and to provide appropriate treatment. Multisystem-Inflammatory-Syndromes following COVID-19 vaccination remain rare events. When a history of a recent contact with SARS-CoV-2 is present, a careful evaluation by the clinicians in charge of immunization activities is suggested prior to proceeding with the vaccination.

Keywords: COVID-19 vaccination; mild encephalitis/encephalopathy with reversible splenial lesion (MERS); multisystem inflammatory syndrome following SARS-CoV-2 vaccination (MIS-V); multisystem inflammatory syndrome in children (MIS-C); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Patient 1 MRI images at the onset showed a hyperintense lesion in the splenium of corpus callosum restricted in DWI/ADC (B,C), with only low- hyperintensity in FLAIR (A) and T2 w images (D). Images (EH) demonstrated normalization of MRI alteration in the splenial region.
Figure 2
Figure 2
MRI performed at the onset for patient 2 showed focal high signal intensity of splenium of the corpus callosum in diffusion-weighted images (DWI) (A) and low signal in ADC map (B) in the same lesion. Axial FLAIR (C) and coronal T2 w (D) images confirmed the presence of a hyperintense splenial lesion. MRI performed one month later revealed complete resolution of the lesion and normal signal intensity of splenium of corpus callosum (EH).

References

    1. Feldstein L.R., Tenforde M.W., Friedman K.G., Newhams M., Rose E.B., Dapul H., Soma V.L., Maddux A.B., Mourani P.M., Bowens C., et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. JAMA. 2021;325:1074–1087. doi: 10.1001/jama.2021.2091. - DOI - PMC - PubMed
    1. Abdel-Mannan O., Eyre M., Löbel U., Bamford A., Eltze C., Hameed B., Hemingway C., Hacohen Y. Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children. JAMA Neurol. 2020;77:1440–1445. doi: 10.1001/jamaneurol.2020.2687. - DOI - PMC - PubMed
    1. Bektas G., Akcay N., Boydag K., Sevketoglu E. Reversible splenial lesion syndrome associated withSARS-CoV-2 infection in two children. Brain Dev. 2021;43:230–233. doi: 10.1016/j.braindev.2020.10.002. - DOI - PMC - PubMed
    1. Walter E.B., Talaat K.R., Sabharwal C., Gurtman A., Lockhart S., Paulsen G.C., Barnett E.D., Muñoz F.M., Maldonado Y., Pahud B.A., et al. Evaluation of the BNT162b2 COVID-19 Vaccine in Children 5 to 11 Years of Age. N. Engl. J. Med. 2022;386:35–46. doi: 10.1056/NEJMoa2116298. - DOI - PMC - PubMed
    1. Garg R.K., Paliwal V.K. Spectrum of neurological complications following COVID-19 vaccination. Neurol. Sci. 2022;43:3–40. doi: 10.1007/s10072-021-05662-9. - DOI - PMC - PubMed

Publication types

LinkOut - more resources